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Background: Post-operative lymph leak is a potentially serious complication which may contribute to
ﬂuid and electrolyte imbalance, malnutrition and an increase risk of sepsis and mortality.
We aimed to study the use of TPN in the treatment of post-operative lymph leak.
Methods: Retrospective review of prospectively collected clinical database comprising patients with post-
operative lymph leak treated with TPN collected over 1998e2006. An analysis of morbidity and mortality
was performed.
Results: 36 patients developed lymph leak following radical neck dissection (n¼ 10), Whipples procedure
(n¼ 13), oesophagectomy (n¼ 10) and pulmonary/vascular/retroperitoneal (n¼ 3) surgery. The survival
to discharge was 89%. The mortality rate in patients with chylothorax following oesophagectomy was
30% (three out of ten). The majority of patients (67%, 24 out of 36) with lymph leak settled on TPN alone.
The overall re-intervention rate was 20%. Of the seven survivors after oesophagectomy, ﬁve underwent
re-intervention thoracic surgery (two also had ischaemic perforation of gastric remnant needing revision
surgery). Overall, the re-intervention rate in all patients undergoing oesophageal surgery is 60%.
Conclusion: Most patients with post-operative lymph leak receiving TPN alone survived. It is rare for re-
operation to be necessary in patients who have lymph leaks in the neck or retroperitoneum. Re-operative
intervention is more commonly performed in lymph leak after oesophagectomy.
 2010 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Lymph leak is a rare but potentially serious complication
following major surgery of the neck,1 chest,2 abdomen,3 axilla4 and
groin.5 Untreated, it may result in hyponatraemia, hypo-
proteinaemia, oedema and malnutrition with decreased immune
function which may contribute to sepsis and increased mortality.
Most patients with lymph leak are treated conservatively in the
ﬁrst instance. Such treatment may include oral or/and intra-venous
ﬂuid, oral diet, somatostatin analogue, total parenteral nutrition
(TPN) and others. Failure to resolve usually necessitates operative
intervention. Many treatments ranging from dietary modiﬁcation,6
pharmacological treatment (somatostatin analogue,7,8 pancreatic
lipase inhibitor9), tissue sealant (e.g. ﬁbrin glue,10 canoacrylate,11
pressure dressing and vacuum-assisted device), interventional
radiological procedures12 to direct surgical repair13e15 have been
reported. However, most studies have included a small number of
patients and it remains difﬁcult to identify the best treatment
strategy.We report our experience in the use of TPN and clear ﬂuidsþ65 6357 7809.
(C. Seow).
ciates Ltd. Published by Elsevier Ltorally in the treatment of post-operative lymph leak in one
institution.
2. Methods
Between January 1998 and December 2006, data were collected prospectively
from all patients receiving TPN (n¼ 442) in our hospital. 36 patients received TPN
because of post-operative lymph leak greater than 500 ml over 48 h.
All patients were cared for in the Department of Surgery, Glasgow Royal Inﬁr-
mary during their TPN treatment by a multi-disciplinary nutrition team. Once the
decision had been made that parenteral nutritionwas appropriate, each patient was
reviewed by the senior surgical dietitian who estimated their nitrogen and energy
requirements. One of four standard commercially prepared three chamber paren-
teral nutrition bags (with Nitrogen content between 9 and 14 g and total energy
between 1600 kcals and 2500 kcals) was selected for use depending on patient
requirements, with electrolytes and ﬂuid volume adjusted depending on ﬂuid losses
and serum electrolytes. Vitamins and trace elements were added in the pharmacy
sterile supplies unit. No glutamine supplementation was used. A single consultant
surgeon supervised or performed the insertion of a dedicated central parenteral
nutrition line for TPN. Patients were permitted clear ﬂuids orally only and parenteral
nutrition was continued until the leakage of lymph had been stopped for at least
48 h. At this stage oral food intake was introduced over several days and parenteral
nutrition stopped when oral intake was judged to be at least half of the estimated
requirements and if no further lymph leak had occurred.
Prospective data were collected about date of admission and operation,
indication for parenteral nutrition, line insertion site and complications, TPN
prescription, dates of starting and stopping TPN, dates and nature of any otherd. All rights reserved.
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tions collected include inability to site parenteral nutrition line; misplacement of
parenteral nutrition line; pneumothorax secondary to parenteral nutrition line
placement; line infection (septicaemia, exit site or tunnel infection felt to be
secondary to parenteral nutrition line, i.e. positive cultures from line site or
central line blood in the absence of other infection source and with symptoms
and signs settling on removal of line).
The main outcomes were survival to discharge; cessation of lymph leak with
TPN alone; length of TPN and length of hospital stay; need for further intervention
and complications. The need for surgical interventionwas left to the discretion of the
individual surgeon.3. Results
There were 14 women and 22 men, with a median age of 62
years (range 38e87). Of these, 10 underwent radical neck dissec-
tion, 13 Whipple’s procedure (pancreaticoduodenectomy), 10
oesophagectomy, one abdominal aneurysm repair, one pulmonary
resection and one radical adrenalectomy (for hepatocellular
metastases). All operations were performed for malignant disease
except one oesophagectomy which was performed for Boerhaave
syndrome.
The survival to discharge in all patients was 89% (32 of 36; 9
of 10 radical neck dissection; 13 of 13 Whipple’s procedure; 7 of
10 oesophagectomy). One non-survivor had bilateral radical neck
dissection with radial forearm ﬂap for cancer of uvula and palate
but developed unilateral lymph leak, contralateral pneumothorax,
neck cellulitis and died of multi-organ failure, unrelated to the
lymph leak or TPN. One had Ivor-Lewis oesophagectomy for
a neo-adjuvant chemotherapy-treated squamous cell carcinoma
of oesophagus and developed early lymph leak (which was
successfully treated with TPN) but died of hospital acquired
pneumonia on the 43rd post-operative day; a second patient had
a radical McKeown 3-stage oesophagectomy, developed cardiac
arrest associated with pulseless electrical activity and died of
irreversible ischaemic brain injury. The lymph leak developed as
a secondary adverse event which was present at the time of
death. The third patient underwent thoracotomy for persistent
lymph leak despite TPN treatment but died of respiratory failure.
67% (24 out of 36) of patients with lymph leak settled on TPN
alone. The response rate for radical neck dissection was 90% (9 of
10), for Whipple’s procedure was 92% (12 of 13) and for oesopha-
gectomy was 30% (3 of 10). Two patients developed recurrent
lymph leak needing re-introduction of TPN but it eventually settled
spontaneously.
The mean length of TPN treatment was 16 days (standard
deviation SD¼ 14 days) in survivors. This did not differ between
patient groups (radical neck dissection (16 days), Whipple’s
procedure (18 days), and oesophagectomy (15 days)).
The mean hospital stay of survivors was 39 days (SD¼ 35 days).
This was longer in surviving patients undergoing oesophagectomy
(mean¼ 63 days) than in patients who had radical neck dissection
(35 days) and Whipple’s procedure (35 days).
Re-intervention was needed in seven patients. One patient with
chylous ascites required the placement of a peritoneovenous shunt
for persistent lymph leak. Of the three non-survivors after oeso-
phagectomy, one responded to TPN alone; one had re-thoracotomy
and one had persistent lymph leak at the time of death. Of the
seven survivors after oesophagectomy, ﬁve underwent re-inter-
vention thoracic surgery (two also had ischaemic perforation of
gastric remnant needing revision surgery). Overall, the re-inter-
vention rate in all lymph leak patients who had undergone oeso-
phageal surgery was 60%.
One patient developed parenteral nutrition line sepsis which
was treated by line replacement. There were no other complica-
tions of TPN.4. Discussion
This is the largest study in the literature which compares the
outcome of iatrogenic lymph leak across various body zones after
major surgery and treated with TPN. Whilst lymph leak may occur
following axillary or inguinal lymph node dissection and also
peripheral vascular surgery, it is usually self-limiting and does not
require TPN. Therefore such cases have been excluded in our series.
This may also reﬂect case mix and practice at our institution. Our
study shows that TPN, used in the management of post-operative
lymph leak, can be safely administered by a dedicated multi-
disciplinary team with minimal morbidity.
The thoracic duct, cisterna chyli and right lymphatic duct are the
main lymphatic trunks which transport lymph and digested fat into
the venous system. The cisterna chyli is an elongated and some-
times dilated sac in the retrocrural space at the level of L2. It
receives the right and left lumbar trunks, intestinal trunk and the
lowest intercostal vessels. The thoracic duct has three components:
abdominal, thoracic and cervical. The abdominal part starts from
the cranial part of the cisterna chyli, passes through the diaphragm
to enter the posterior mediastinum to form the thoracic part.
During its ascent, the thoracic duct is closely related to the hemi-
azygous vein, oesophagus, diaphragm and pericardium. It then
drains into the left subclavian vein. The right lymphatic duct drains
the right hemithorax, right head and neck and also the right
extremity. Several variations have been described on the pattern of
termination of the thoracic duct and also the right lymphatic duct
into the venous system.16 The variable anatomy of the thoracic duct
lends itself to injury during surgery of head and neck, oesophagus,
abdominal or thoracic aorta, pancreas and other retroperitoneal
structures.
Absorption of fat takes place in the small intestine in the form of
chylomicrons. Fatty acids with greater than 10 carbon atom are
mostly transported in lacteals (lymphatic capillaries) via the
lymphatic vessels and thoracic duct into the circulatory system.
Smaller fatty acids (fewer than ten carbon atoms) are preferentially
transported in the portal venous system. It is estimated that 3e5 l
of lymph ﬂuid passes through the thoracic duct daily. The volume of
ﬂow through the thoracic duct is between 60 and 190 ml/h. An
increase in the lymph ﬂow across the thoracic duct is seen during
absorption phase of digestion. Conversely, a decrease is seen in
fasting; consumption of a modiﬁed medium-chain triglyceride
(MCT) diet17 or a fat-free diet18; mechanical ventilation19 and also
the administration of TPN,20 somatostatin analogue,21 vasocon-
strictor22 and pancreatic lipase inhibitor.9 These measures have
been used in various combinations in the treatment of post-oper-
ative lymph leak.
The principles of treatment of lymph leak are: reduction of the
lymphatic ﬂow by physiological or pharmacological manipula-
tion; replacement of ﬂuid and electrolytes and maintenance of
nutrition; tissue sealant-related agent or devices and interven-
tional procedure and/or direct surgical closure. In almost all
series, nutritional replacement and supplement is felt to be a vital
part of support for the patient. Most reports of successful treat-
ment of lymph leak using innovative therapy comprise of small
anecdotal cases of different case mix and are reﬂective of insti-
tutional practice.
In our practice, the objectives of reducing lymph ﬂow across
main lymphatic ducts and providing nutrition support could be
accomplished by a combination regimen of simple clear ﬂuid and
TPN. Spontaneous closure of lymph leak was possible in the
majority of cases whilst parenteral nutrition was able to meet the
estimated nutritional requirements and to replace loss of ﬂuid and
electrolytes. Although the use of low-fat MCT diet has been known
to reduce lymph leak, it is not used routinely in our practice as it
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providing the nutrition needed.
Across the body zones, lymph leak in patients after head and
neck and also abdominal surgery usually responded to fasting, oral
clear ﬂuids and parenteral nutrition alone. However, lymph leak in
patients undergoing oesophageal surgery appeared to be an
adverse event associated with a signiﬁcant re-intervention rate
(60%) and mortality (30%). This was an observational study rather
than a randomised study but the ﬁnding that intervention was
commonly undertaken for lymph leak in the thorax is consistent
with other published literature.2,23e25 This may be explained by the
extensive injury or even complete extirpation to the lymphatic
system after oesophagectomy which is unlikely, or in some
instances impossible, to heal without surgical intervention. A
space-occupying, septated collection of lymph in the pleural cavity
is associated with a decrease in pulmonary volume, increase in
intra-pleural pressure with ventilation/perfusion imbalance. This
may predispose to pneumonia, sepsis and respiratory failure.
However, lymph leak may also simply represent a secondary event
associated with the complicated course of patients after oesopha-
gectomy. In the literature, the mortality of lymph leak following
oesophagectomy varies from 0% to 50%.23,24,26 Early ligation of
thoracic duct (within 48 h) is thought to be associated with a lower
mortality of 10e16%.25 Recently, an interventional technique using
percutaneous lymphangiography and embolization of cisterna chyli
has been reported with success.27,28
This was an observational rather than an experimental study.
Nevertheless, our study shows that the use of TPN by a dedicated
multi-disciplinary team may be an effective primary treatment
modality in the majority of patients with post-operative
lymph leak.5. Conclusion
In summary, the prognosis of post-operative lymph leak is
primarily related to its body zone. After head and neck and also
abdominal surgery most lymph leaks respond well with TPN alone.
However, in patients undergoing oesophageal surgery, re-operative
intervention seems to be more commonly needed.
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